Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague.
Biryukov SS, Wu H, Dankmeyer JL, Rill NO, Klimko CP, Egland KA, Shoe JL, Hunter M, Fetterer DP, Qiu J, Davies ML, Bausch CL, Sullivan EJ, Luke T, Cote CK. Biryukov SS, et al. Among authors: rill no. Antibodies (Basel). 2023 May 8;12(2):33. doi: 10.3390/antib12020033. Antibodies (Basel). 2023. PMID: 37218899 Free PMC article.
Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V Vaccine.
Biryukov S, Dankmeyer JL, Shamsuddin Z, Velez I, Rill NO, Rosario-Acevedo R, Klimko CP, Shoe JL, Hunter M, Ward MD, Cazares LH, Fetterer DP, Bozue JA, Worsham PL, Cote CK, Amemiya K. Biryukov S, et al. Among authors: rill no. Front Immunol. 2021 Aug 27;12:726416. doi: 10.3389/fimmu.2021.726416. eCollection 2021. Front Immunol. 2021. PMID: 34512658 Free PMC article.
Evaluation of two different vaccine platforms for immunization against melioidosis and glanders.
Biryukov SS, Cote CK, Klimko CP, Dankmeyer JL, Rill NO, Shoe JL, Hunter M, Shamsuddin Z, Velez I, Hedrick ZM, Rosario-Acevedo R, Talyansky Y, Schmidt LK, Orne CE, Fetterer DP, Burtnick MN, Brett PJ, Welkos SL, DeShazer D. Biryukov SS, et al. Among authors: rill no. Front Microbiol. 2022 Aug 17;13:965518. doi: 10.3389/fmicb.2022.965518. eCollection 2022. Front Microbiol. 2022. PMID: 36060742 Free PMC article.
Functional assays to screen and select monoclonal antibodies that target Yersinia pestis.
Biryukov SS, Rill NO, Klimko CP, Dankmeyer JL, Shoe JL, Hunter M, Talyansky Y, Hau D, Gates-Hollingsworth MA, Pandit SG, Fetterer DP, Qiu J, Davies ML, AuCoin DP, Cote CK. Biryukov SS, et al. Among authors: rill no. Hum Vaccin Immunother. 2023 Aug 1;19(2):2216085. doi: 10.1080/21645515.2023.2216085. Epub 2023 Jun 8. Hum Vaccin Immunother. 2023. PMID: 37289480 Free PMC article.
Virulence of Burkholderia pseudomallei ATS2021 Unintentionally Imported to United States in Aromatherapy Spray.
Cote CK, Mlynek KD, Klimko CP, Biryukov SS, Mou S, Hunter M, Rill NO, Dankmeyer JL, Miller JA, Talyansky Y, Davies ML, Meinig JM, Halasohoris SA, Gray AM, Spencer JL, Babyak AL, Hourihan MK, Curry BJ, Toothman RG, Ruiz SI, Zeng X, Ricks KM, Clements TL, Douglas CE, Ravulapalli S, Stefan CP, Shoemaker CJ, Elrod MG, Gee JE, Weiner ZP, Qiu J, Bozue JA, Twenhafel NA, DeShazer D. Cote CK, et al. Among authors: rill no. Emerg Infect Dis. 2024 Oct;30(10):2056-2069. doi: 10.3201/eid3010.240084. Emerg Infect Dis. 2024. PMID: 39320153 Free PMC article.
Characterization of two affinity matured Anti-Yersinia pestis F1 human antibodies with medical countermeasure potential.
Velappan N, Biryukov SS, Rill NO, Klimko CP, Rosario-Acevedo R, Shoe JL, Hunter M, Dankmeyer JL, Fetterer DP, Bedinger D, Phipps ME, Watt AJ, Abergel RJ, Dichosa A, Kozimor SA, Cote CK, Lillo AM. Velappan N, et al. Among authors: rill no. PLoS One. 2024 Jul 2;19(7):e0305034. doi: 10.1371/journal.pone.0305034. eCollection 2024. PLoS One. 2024. PMID: 38954719 Free PMC article.
11 results